Ohio State University
Overview
The Ohio State University engages in investment activities through several entities. The Office of Investments manages the university's Long-Term Investment Pool (LTIP), acting primarily as a Limited Partner (LP) by partnering with external fund managers. Direct investment and commercialization are handled by the Technology Commercialization Office (TCO) and the Tim & Kathleen Keenan Center for Entrepreneurship. The university provides direct funding to startups through programs like the 'Accelerator Awards,' which grants up to $150,000 to commercialize university intellectual property, and the 'President's Buckeye Accelerator,' which awards $50,000 to student-led ventures. OSU also invests in external venture capital funds, such as Rev1 Ventures' Future Value Fund I and Drive Capital.
Portfolio Companies
4
Website
osu.eduInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Optain Health | Sep 2025 | Series A | Co-investor |
| Optain Health | Sep 2025 | Series A | Co-investor |
| Neucore Bio | Feb 2024 | Seed | Co-investor |
| Smalls | Mar 2023 | Series B | Co-investor |
| CapSen Robotics | Jan 2022 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.